ClinRé 001-022 (Premier Cancer Care and Infusion Center) — Fresno, California

ClinRé 001-022 (Premier Cancer Care and Infusion Center) is a clinical research site located in Fresno, California, United States 93710.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

ClinRé 001-022 (Premier Cancer Care and Infusion Center) has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Non-small Cell Lung Cancer, Lung Cancer, Non-squamous, Non-small Cell.

Sponsors: Boehringer Ingelheim.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fresno

Browse all research sites in California · View every site in Fresno

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for ClinRé 001-022 (Premier Cancer Care and Infusion Center)?

ClinRé 001-022 (Premier Cancer Care and Infusion Center) has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has ClinRé 001-022 (Premier Cancer Care and Infusion Center) conducted?

ClinRé 001-022 (Premier Cancer Care and Infusion Center) has 2 clinical trials on record, with 2 currently active. Their work covers Non-small Cell Lung Cancer, Lung Cancer, Non-squamous, Non-small Cell.

Is ClinRé 001-022 (Premier Cancer Care and Infusion Center) accredited by Crixeo Clinical Trials?

ClinRé 001-022 (Premier Cancer Care and Infusion Center) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about ClinRé 001-022 (Premier Cancer Care and Infusion Center)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.